Needham & Company LLC reissued their buy rating on shares of DocGo (NASDAQ:DCGO - Free Report) in a report released on Thursday,Benzinga reports. Needham & Company LLC currently has a $7.00 price target on the stock.
Separately, Cantor Fitzgerald restated an "overweight" rating and set a $5.00 target price on shares of DocGo in a report on Friday, September 20th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, DocGo has an average rating of "Buy" and an average price target of $6.10.
Check Out Our Latest Stock Analysis on DCGO
DocGo Price Performance
NASDAQ DCGO traded up $0.10 on Thursday, reaching $4.28. 225,118 shares of the company's stock traded hands, compared to its average volume of 343,410. The stock has a market cap of $436.26 million, a PE ratio of 15.27, a P/E/G ratio of 11.49 and a beta of 0.97. DocGo has a 12 month low of $2.75 and a 12 month high of $4.86. The stock has a 50-day simple moving average of $4.21 and a 200 day simple moving average of $3.68.
Insider Activity
In other news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total value of $102,510.72. Following the sale, the general counsel now directly owns 175,645 shares in the company, valued at approximately $779,863.80. This trade represents a 11.62 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.70% of the company's stock.
Institutional Trading of DocGo
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp increased its position in DocGo by 40.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 343,761 shares of the company's stock valued at $1,062,000 after purchasing an additional 99,359 shares during the period. Rhumbline Advisers increased its position in shares of DocGo by 33.4% during the second quarter. Rhumbline Advisers now owns 146,188 shares of the company's stock valued at $452,000 after buying an additional 36,613 shares during the period. Victory Capital Management Inc. raised its stake in DocGo by 124.0% in the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company's stock worth $79,000 after buying an additional 14,191 shares in the last quarter. XTX Topco Ltd purchased a new stake in DocGo in the second quarter worth about $211,000. Finally, Marshall Wace LLP lifted its holdings in DocGo by 212.4% in the second quarter. Marshall Wace LLP now owns 505,514 shares of the company's stock worth $1,562,000 after buying an additional 343,692 shares during the period. Hedge funds and other institutional investors own 56.44% of the company's stock.
About DocGo
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
